A detailed history of Jpmorgan Chase & CO transactions in In Mode Ltd. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 1,184,051 shares of INMD stock, worth $21.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,184,051
Previous 388,206 205.01%
Holding current value
$21.3 Million
Previous $8.39 Million 157.44%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$17.02 - $21.0 $13.5 Million - $16.7 Million
795,845 Added 205.01%
1,184,051 $21.6 Million
Q1 2024

May 10, 2024

BUY
$20.45 - $26.49 $2.16 Million - $2.8 Million
105,675 Added 37.4%
388,206 $8.39 Million
Q4 2023

Feb 12, 2024

SELL
$19.02 - $30.13 $89,222 - $141,339
-4,691 Reduced 1.63%
282,531 $6.28 Million
Q3 2023

Nov 14, 2023

SELL
$30.46 - $46.04 $1.64 Million - $2.48 Million
-53,867 Reduced 15.79%
287,222 $8.75 Million
Q2 2023

Aug 11, 2023

BUY
$31.57 - $37.73 $78,956 - $94,362
2,501 Added 0.74%
341,089 $12.7 Million
Q1 2023

May 11, 2023

BUY
$29.72 - $41.45 $2.64 Million - $3.68 Million
88,745 Added 35.52%
338,588 $10.8 Million
Q4 2022

Feb 13, 2023

BUY
$30.23 - $38.71 $5.33 Million - $6.82 Million
176,190 Added 239.22%
249,843 $8.92 Million
Q3 2022

Nov 14, 2022

BUY
$22.51 - $38.27 $322,050 - $547,528
14,307 Added 24.11%
73,653 $2.14 Million
Q2 2022

Aug 11, 2022

SELL
$20.97 - $37.47 $419,127 - $748,912
-19,987 Reduced 25.19%
59,346 $1.33 Million
Q1 2022

May 11, 2022

BUY
$34.38 - $65.77 $1.5 Million - $2.87 Million
43,646 Added 122.3%
79,333 $2.93 Million
Q4 2021

Feb 10, 2022

SELL
$63.78 - $97.86 $6.1 Million - $9.37 Million
-95,710 Reduced 72.84%
35,687 $2.52 Million
Q3 2021

Nov 12, 2021

BUY
$45.58 - $88.24 $5.99 Million - $11.6 Million
131,397 New
131,397 $21 Million

Others Institutions Holding INMD

About InMode Ltd.


  • Ticker INMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,081,104
  • Market Cap $1.49B
  • Description
  • InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedur...
More about INMD
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.